These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 20083021)
21. Updates in Stroke Treatment. Mac Grory B; Yaghi S R I Med J (2013); 2018 Mar; 101(2):30-33. PubMed ID: 29490322 [TBL] [Abstract][Full Text] [Related]
22. Ischemic stroke. Clinical strategies based on mechanisms and risk factors. Hemphill JC Geriatrics; 2000 Mar; 55(3):42, 47-8, 51-2. PubMed ID: 10732004 [TBL] [Abstract][Full Text] [Related]
23. Current approaches to anticoagulation for reducing risk of atrial fibrillation-related stroke. Sanoski CA J Pharm Pract; 2013 Jun; 26(3):204-13. PubMed ID: 22842506 [TBL] [Abstract][Full Text] [Related]
24. Echocardiographic findings that may help identify occult intermittent atrial fibrillation in hypertensive patients at risk for a second (or first) ischemic stroke. Haft JI Stroke; 2008 Jun; 39(6):e91; author reply e92. PubMed ID: 18436871 [No Abstract] [Full Text] [Related]
25. [The EMBRACE study]. Gaita F; Anselmino M; Sessa M G Ital Cardiol (Rome); 2015 Jan; 16(1):1-5. PubMed ID: 25689744 [No Abstract] [Full Text] [Related]
26. In-hospital initiation of secondary prevention is associated with improved vascular outcomes at 3 months. Rahiman A; Saver JL; Porter V; Buxton W; McNair N; Razinia T; Ovbiagele B J Stroke Cerebrovasc Dis; 2008; 17(1):5-8. PubMed ID: 18190814 [TBL] [Abstract][Full Text] [Related]
27. High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Schwartz GG; Chaitman BR; Goldberger JJ; Messig M Am Heart J; 2011 May; 161(5):993-9. PubMed ID: 21570534 [TBL] [Abstract][Full Text] [Related]
28. Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation. Liew A; Eikelboom JW; O'Donnell M Curr Opin Cardiol; 2012 Jul; 27(4):331-9. PubMed ID: 22573171 [TBL] [Abstract][Full Text] [Related]
30. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack. Davis SM; Donnan GA N Engl J Med; 2012 May; 366(20):1914-22. PubMed ID: 22591297 [No Abstract] [Full Text] [Related]
31. [Antithrombotic therapy for stroke prevention in patients with atrial fibrillation]. Tomita F; Kohya T; Kitabatake A Nihon Rinsho; 2000 Jun; 58(6):1326-34. PubMed ID: 10879060 [TBL] [Abstract][Full Text] [Related]
32. [Social impact of stroke due to atrial fibrillation]. Santamarina E; Alvarez Sabín J Neurologia; 2012 Mar; 27 Suppl 1():10-4. PubMed ID: 22682205 [TBL] [Abstract][Full Text] [Related]
33. Ask the doctor. Recently I read that aspirin can actually increase a person's risk for a stroke by causing bleeding in the brain. I have atrial fibrillation and my doctor wants me to take a blood thinner - if not warfarin, then at least aspirin. I've already had a heart attack and I don't want to run the risk of a stroke, so I have refused. What should I do? Lee TH Harv Heart Lett; 2000 Sep; 11(1):7. PubMed ID: 10966583 [No Abstract] [Full Text] [Related]
34. Can the WATCHMAN device truly PROTECT from stroke in atrial fibrillation? Wrigley BJ; Lip GY Lancet Neurol; 2009 Oct; 8(10):877-8. PubMed ID: 19747647 [No Abstract] [Full Text] [Related]
35. Asymptomatic atrial fibrillation after cryptogenetic stroke: incidence, clinical significance, and therapeutic implications. Raviele A Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):249-51. PubMed ID: 25900985 [No Abstract] [Full Text] [Related]
36. Nonpharmacologic approaches to stroke prevention in atrial fibrillation. Whitlock RP; Hanif H; Danter M Can J Cardiol; 2013 Jul; 29(7 Suppl):S79-86. PubMed ID: 23790602 [TBL] [Abstract][Full Text] [Related]
37. Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis. Agarwal S; Hachamovitch R; Menon V Arch Intern Med; 2012 Apr; 172(8):623-31; discussion 631-3. PubMed ID: 22450212 [TBL] [Abstract][Full Text] [Related]
38. The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation. Singer DE; Fang MC; Go AS Arch Intern Med; 2009 Nov; 169(21):2032; author reply 2033. PubMed ID: 19933969 [No Abstract] [Full Text] [Related]
39. Warfarin may reduce risk of ischemic stroke by preventing atrial fibrillation for patients with heart failure and sinus rhythm. Lin GM; Li YH; Jaiteh LE; Han CL Int J Cardiol; 2013 Apr; 164(2):245-6. PubMed ID: 22795713 [No Abstract] [Full Text] [Related]
40. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]